EXPRESSION OF THE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 (HIV-1) NEF GENE DURING HIV-1 PRODUCTION INCREASES PROGENY PARTICLE INFECTIVITY INDEPENDENTLY OF GP160 OR VIRAL ENTRY

被引:118
|
作者
MILLER, MD
WARMERDAM, MT
PAGE, KA
FEINBERG, MB
GREENE, WC
机构
[1] UNIV CALIF SAN FRANCISCO,DEPT MICROBIOL & IMMUNOL,SAN FRANCISCO,CA 94114
[2] UNIV CALIF SAN FRANCISCO,DEPT MED,SAN FRANCISCO,CA 94114
关键词
D O I
10.1128/JVI.69.1.579-584.1995
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
The nef gene product of human immunodeficiency virus type 1 (HIV-1) promotes more-rapid kinetics of viral replication in primary peripheral blood mononuclear cells. We have previously shown that these enhancing effects of Nef on HIV-1 replication reflect an increase in viral infectivity detectable both in limiting dilution assays and through a single-cycle infection of the HeLa-CD4-long terminal repeat-beta-galactosidase indicator cell line. We now demonstrate that nef-defective HIV-1 can be rescued to near wild-type levels of infectivity by coexpressing Nef in trans in the cell line producing the virus. This observation indicates that HIV-1 virions produced in the presence of Nef are intrinsically different. However, we show that the major viral structural proteins are quantitatively similar in purified viral preparations. We also demonstrate the functional equivalence of the gp120-gp41 envelope glycoprotein complexes of Nef(+) and Nef HIV-1 through an assay for viral entry. Finally, we show that env-defective Nef(+) HIV-1 pseudotyped with an amphotropic envelope is also more infectious than similarly pseudotyped Nef HIV-1. Thus, the production of HIV-1 in the presence of Nef results in viral particles that are more infectious, and this increased infectivity is manifested at a stage after viral entry but prior to or coincident with HIV-1 gene expression.
引用
收藏
页码:579 / 584
页数:6
相关论文
共 50 条
  • [1] EXPRESSION OF THE HIV-1 NEF GENE DURING HIV-1 PRODUCTION INCREASES PROGENY PARTICLE INFECTIVITY INDEPENDENTLY OF GP160 OR VIRAL ENTRY
    MILLER, MD
    WARMERDAM, MT
    PAGE, KA
    FEINBERG, MB
    GREENE, WC
    JOURNAL OF CELLULAR BIOCHEMISTRY, 1995, : 194 - 194
  • [2] THE SAFETY AND IMMUNOGENICITY OF A HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 (HIV-1) RECOMBINANT GP160 CANDIDATE VACCINE IN HUMANS
    DOLIN, R
    GRAHAM, BS
    GREENBERG, SB
    TACKET, CO
    BELSHE, RB
    MIDTHUN, K
    CLEMENTS, ML
    GORSE, GJ
    HORGAN, BW
    ATMAR, RL
    KARZON, DT
    BONNEZ, W
    FERNIE, BF
    MONTEFIORI, DC
    STABLEIN, DM
    SMITH, GE
    KOFF, WC
    ANNALS OF INTERNAL MEDICINE, 1991, 114 (02) : 119 - 127
  • [3] DEFINING THE LEVEL OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 (HIV-1) PROTEASE ACTIVITY REQUIRED FOR HIV-1 PARTICLE MATURATION AND INFECTIVITY
    ROSE, JR
    BABE, LM
    CRAIK, CS
    JOURNAL OF VIROLOGY, 1995, 69 (05) : 2751 - 2758
  • [4] LECTIN CARBOHYDRATE INTERACTIONS AND INFECTIVITY OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 (HIV-1)
    GATTEGNO, L
    RAMDANI, A
    JOUAULT, T
    SAFFAR, L
    GLUCKMAN, JC
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 1992, 8 (01) : 27 - 37
  • [5] MYOPATHY WITH HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 (HIV-1) INFECTION - HIV-1 OR ZIDOVUDINE
    TILL, M
    MACDONELL, KB
    ANNALS OF INTERNAL MEDICINE, 1990, 113 (07) : 492 - 494
  • [6] HUMAN-IMMUNODEFICIENCY-VIRUS (HIV-1) GP160-SPECIFIC LYMPHOCYTE PROLIFERATIVE RESPONSES OF MONONUCLEAR LEUKOCYTES FROM HIV-1 RECOMBINANT GP160 VACCINE RECIPIENTS
    KEEFER, MC
    BONNEZ, W
    ROBERTS, NJ
    DOLIN, R
    REICHMAN, RC
    JOURNAL OF INFECTIOUS DISEASES, 1991, 163 (03): : 448 - 453
  • [7] HIV-1 (HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1) - INFECTION AND DETECTION
    ZEICHHARDT, H
    ZORR, B
    HAMPL, H
    WILLINGMANN, P
    BUCHOW, H
    MAXEINER, HG
    HABERMEHL, KO
    ARZTLICHE LABORATORIUM, 1987, 33 (11): : 253 - 258
  • [8] Antibody to human immunodeficiency virus type 1 (HIV-1) gp160 in mucosal specimens of asymptomatic HIV-1-infected volunteers parenterally immunized with an experimental recombinant HIV-1 IIIB gp160 vaccine
    Lambert, JS
    Viscidi, R
    Walker, MC
    Clayman, B
    Winget, M
    Wolff, M
    Schwartz, DH
    CLINICAL AND DIAGNOSTIC LABORATORY IMMUNOLOGY, 1997, 4 (03) : 302 - 308
  • [9] POTENT INHIBITION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 (HIV-1) REPLICATION BY INDUCIBLE EXPRESSION OF HIV-1 PR MULTIMERS
    ARRIGO, SJ
    HUFFMAN, K
    JOURNAL OF VIROLOGY, 1995, 69 (10) : 5988 - 5994
  • [10] BINDING OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 (HIV-1) RNA TO RECOMBINANT HIV-1 GAG POLYPROTEIN
    LUBAN, J
    GOFF, SP
    JOURNAL OF VIROLOGY, 1991, 65 (06) : 3203 - 3212